We invest and manage our real estate portfolio for the long-term to maximize the benefit to our stockholders and support the growth of our dividends. The core elements of our strategy are to:
- Acquire, develop, lease, own and manage a diversified portfolio of quality healthcare properties across multiple business segments and geographic locations (including Europe)
- Align ourselves with leading healthcare companies, operators and service providers, which over the long term should result in higher relative rental rates, net operating cash flows and appreciation of property values
- Allocate capital targeting a balanced portfolio between longer-term escalating triple-net leases with quality tenants, and operating businesses with shorter-term leases in medical and life science office and senior housing RIDEA
- Maintain adequate liquidity with long-term fixed rate debt financing with staggered maturities, which supports the longer-term nature of our investments, while reducing our exposure to interest rate volatility and refinancing risk at any point in the interest rate or credit cycles
- Continually manage our balance sheet with a targeted financial leverage to 40% relative to our assets.
Company Growth (employees)
HCP was founded in 1985 and is headquartered in Saint Paul, US
HCP Office Locations
HCP has offices in Saint Paul, Irvine, Franklin and Foster City
HCP Data and Metrics
HCP Financial Metrics
HCP's revenue was reported to be $2.1 b in FY, 2016 which is a 16% decrease from the previous period.
USD
Revenue (FY, 2016) | 2.1 b |
Revenue growth (FY, 2015 - FY, 2016), % | (16%) |
Net income (FY, 2016) | 639.9 m |
Market capitalization (20-Jul-2017) | 14.9 b |
Closing share price (20-Jul-2017) | 32.2 |
HCP's current market capitalization is $14.9 b.
| USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|---|
Revenue | 1.2 b | 1.7 b | 1.9 b | 2.1 b | 2.3 b | 2.5 b | 2.1 b |
Revenue growth, % | 37% | 11% | 12% | 8% | 12% | (16%) | |
General and administrative expense | 103.6 m | ||||||
Operating expense total | 3.1 b | 1.9 b | |||||
EBIT | 870.2 m | 904.3 m | |||||
EBIT margin, % | 41% | 40% | |||||
Interest expense | 285.5 m | 415.5 m | 416.2 m | 435.3 m | 439.7 m | 479.6 m | 464.4 m |
Interest income | 112.2 m | 88.8 m | |||||
Income tax expense | 412 k | 1.3 m | (1.7 m) | 5.8 m | 250 k | (9 m) | (48.2 m) |
Net Income | 985 m | 936.6 m | (546.4 m) | 639.9 m |
| USD | Y, 2009 | Y, 2010 | Y, 2011 | Y, 2012 | Y, 2013 | Y, 2014 | Y, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|---|---|
Cash | 112.3 m | 1 b | 33.5 m | 247.7 m | 300.6 m | 183.8 m | 346.5 m | |
Accounts Receivable | 65.7 m | |||||||
Total Assets | 20.1 b | 21.4 b | 21.4 b | 15.8 b | ||||
Accounts Payable | 417.4 m | |||||||
Total Liabilities | 9.8 b | |||||||
Additional Paid-in Capital | 11.3 b | 11.4 b | 11.6 b | 8.2 b | ||||
Total Equity | 10.9 b | 11 b | 9.7 b | 5.9 b | ||||
Financial Leverage | 1.8 x | 1.9 x | 2.2 x | 2.7 x |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 985 m | 936.6 m | (546.4 m) | 639.9 m |
Depreciation and Amortization | 510.8 m | 568.1 m | ||
Accounts Receivable | 6.7 m | (8.8 m) | (9.6 m) | 3.8 m |
Cash From Operating Activities | 1.1 b | 1.2 b | 1.2 b | 1.2 b |
Cash From Investing Activities | (196.6 m) | (1.5 b) | (1.7 b) | (410.6 m) |
Cash From Financing Activities | (900.4 m) | 144.8 m | 614.1 m | (1.1 b) |
| USD | Y, 2016 |
|---|---|
Revenue/Employee | 11.4 m |
Financial Leverage | 2.7 x |
